EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials

Rong Zeng, Xiaomei Li, Fangfei Wang, Jinliang Xie, Conghua Song iD, Yong Xie iD

Helicobacter · 2023

DOI: 10.1111/hel.12989 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Helicobacter, 2023. Verfasst von Rong Zeng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Helicobacter Infections, Helicobacter pylori. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: High Level Introduction of Talent Research Start-Up Fund, Putian University, National Natural Science Foundation of China, Natural Science Foundation of Fujian Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The eradication rate of Helicobacter pylori ( H. pylori ) remains variable for the same eradication regime even in the identical region, especially in developing countries. Herein, we conducted a systematic review to assess the effect of reinforced medication adherence on H. pylori eradication rate in developing countries. Materials and Methods A systematic review was conducted in literature databases to identify relevant randomized controlled trials (RCTs) from inception to March 2023. The core indicator was the changes in eradication rate after enhanced adherence. A meta‐analysis was performed to estimate the pooled relative risk (RR) or weighted mean difference (WMD) with 95% confidence intervals (CI).

Results

Nineteen RCTs that included a total of 3286 patients were assessed. The measures to enhance compliance were mainly through face‐to‐face communication, phone calls, text messages, and social software. Compared with the control group, patients received reinforced measures showed a better medication adherence (89.6% vs. 71.4%, RR = 1.26 95% CI: 1.16–1.37), higher H. pylori eradication rate (intention‐to‐treat analysis: 80.2% vs. 65.9%, RR = 1.25, 95% CI: 1.12–1.31; per‐protocol analysis: 86.8% vs. 74.8%, RR = 1.16, 95% CI: 1.09–1.23), higher symptom relief rates (81.8% vs. 65.1%, RR = 1.23, 95% CI: 1.09–1.38), higher degree of satisfaction (90.4% vs. 65.1%, RR = 1.26, 95% CI: 1.19–1.35), higher disease knowledge rates (SMD = 1.82, 95% CI: 0.77–2.86, p = 0.0007), and lower incidence of total adverse events (27.3% vs. 34.7%, RR = 0.72, 95% CI: 0.52–0.99).

Conclusion

Based on available evidence, reinforced medication adherence as a nonnegligible measure improves H. pylori eradication rate in developing countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsHelicobacter pyloriHumansAnti-Bacterial AgentsDeveloping CountriesDrug Therapy, CombinationRandomized Controlled Trials as TopicMedication Adherence

Stichwörter der Autor:innen

Helicobacter pyloridisease eradicationdrug-related side effects and adverse reactionsmedication adherencemeta-analysis

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
  • School of Basic Medicine, Medical College of Putian University, Putian, China.
  • Endoscopy Center, the Affiliated Hospital of Putian University, Putian, China.
  • Key Laboratory of Digestive Diseases of Jiangxi Province, Nanchang, China.
  • Jiangxi Clinical Research Center for Gastroenterology, Nanchang, China.

ORCID-Profile: Conghua Song, Yong Xie

Förderung

  • High Level Introduction of Talent Research Start-Up Fund, Putian University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Fujian Province of China
  • the Science and Technology Projects of Jiangxi Province

Zitieren

APA

Zeng, R., Li, X., Wang, F., Xie, J., Song, C., & Xie, Y. (2023). Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials. Helicobacter. https://doi.org/10.1111/hel.12989

Vancouver

Zeng R, Li X, Wang F, Xie J, Song C, Xie Y. Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials. Helicobacter. 2023. doi:10.1111/hel.12989

BibTeX
@article{Zeng2023,
  author = {Zeng, Rong and Li, Xiaomei and Wang, Fangfei and Xie, Jinliang and Song, Conghua and Xie, Yong},
  title = {Reinforced medication adherence improves Helicobacter pylori eradication rate in developing countries: A systematic review and meta‐analysis of randomized controlled trials},
  journal = {Helicobacter},
  year = {2023},
  doi = {10.1111/hel.12989}
}
Kostenlos starten →